# Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

Study · id `cardio:ct-nct01151176` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01151176](<https://clinicaltrials.gov/study/NCT01151176>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01151176

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 130 participants.

## Technical summary

Registry record NCT01151176. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT01151176, source copy `cardio:ctgov-nct01151176-2012-06-19`, retrieved 2026-10-31)
- Start date: 2012-08 (registry gives no type) (ClinicalTrials.gov record NCT01151176, source copy `cardio:ctgov-nct01151176-2012-06-19`, retrieved 2026-10-31)
- Primary completion: 2013-08 (anticipated) (ClinicalTrials.gov record NCT01151176, source copy `cardio:ctgov-nct01151176-2012-06-19`, retrieved 2026-10-31)
- Completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01151176, source copy `cardio:ctgov-nct01151176-2012-06-19`, retrieved 2026-10-31)
- Countries: United States; Brazil (ClinicalTrials.gov record NCT01151176, source copy `cardio:ctgov-nct01151176-2012-06-19`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01151176-2012-06-19`, retrieved 2026-10-31)

## The registry's words

- Brief title: Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Regular Insulin
- Intervention (Drug): Regular Insulin
- Lead sponsor: Universidade Positivo
- Lead sponsor class: OTHER
- Collaborator: Emory University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as a collaborator: Emory University (`cardio:org-emory-university`)

## Provenance

Content hash: d1932fe83ac02b81d45f224d325ae2580b7af56547a68b51440d7cabf2d47804
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
